Over-the-Counter (OTC) Sleep Aids Medication Market Report 2026

The over-the-counter (otc) sleep aids medication market size has grown strongly in recent years. It will grow from $22.69 billion in 2025 to $24.54 billion in 2026 at a compound annual growth rate (CAGR) of 8.1%. The growth in the historic period can be attributed to increasing prevalence of sleep disturbances, widespread availability of otc medications, consumer reliance on antihistamine-based sleep aids, growth of retail pharmacy networks, rising stress and lifestyle-related sleep issues.

The over-the-counter (otc) sleep aids medication market size is expected to see strong growth in the next few years. It will grow to $33.15 billion in 2030 at a compound annual growth rate (CAGR) of 7.8%. The growth in the forecast period can be attributed to growing adoption of melatonin supplements, increasing preference for herbal and cbd-based remedies, expansion of e-commerce and direct-to-consumer sales, rising health awareness and self-care trends, product diversification with added nutrients and extended-release formulations. Major trends in the forecast period include rising consumer preference for non-prescription sleep solutions, growing demand for melatonin and natural sleep aids, increasing awareness of sleep health and short-term sleep management, expansion of online sales channels for otc sleep aids, product innovation with combination and multi-herb formulations.

The increasing prevalence of insomnia is anticipated to drive the growth of the over-the-counter (OTC) sleep aids medication market in the coming years. Insomnia is a sleep disorder marked by difficulty falling asleep, remaining asleep, or waking too early, leading to poor sleep quality and impaired daytime functioning. The growing prevalence of insomnia is largely attributed to rising stress levels, as more individuals experience work-related pressure and everyday challenges that interfere with relaxation and restorative sleep. Over-the-counter sleep aid medications offer accessible and convenient relief for insomnia by helping people fall asleep more quickly and improve sleep quality without requiring a prescription. For instance, in April 2024, according to Oxford University Press, a UK-based publishing company, approximately 19.5% of adult females and 14% of adult males in the Americas were affected by insomnia in 2024, representing nearly 123 million individuals. Therefore, the increasing prevalence of insomnia is fueling the growth of the over-the-counter (OTC) sleep aids medication market.

The rising levels of stress and work-related anxiety are also expected to propel the growth of the over-the-counter (OTC) sleep aids medication market in the coming years. Stress and work-related anxiety involve psychological strain and persistent worry caused by workplace demands, economic pressures, and job-related responsibilities that negatively affect mental health and daily life. The increase in stress and work-related anxiety is driven by economic uncertainty and financial concerns, as worries about job security, expenses, and overall economic conditions create ongoing anxiety among working adults, particularly in post-pandemic work environments. Elevated stress and anxiety directly contribute to greater use of non-prescription sleep medications, as individuals experiencing prolonged tension often develop sleep disturbances and seek readily available sleep aids to manage insomnia and improve rest. For instance, in May 2024, according to the American Psychiatric Association, a US-based professional organization, the proportion of adults reporting higher anxiety than the previous year rose from 32% in 2022 to 37% in 2023 and further increased to 43% in 2024. Therefore, the growing stress and work-related anxiety are driving the growth of the over-the-counter (OTC) sleep aids medication market.

Major companies operating in the over-the-counter (OTC) sleep aids medication market are concentrating on the development of innovative approaches, such as longevity-driven sleep optimization, to deliver personalized and effective solutions that improve sleep quality and support long-term health. Longevity-driven sleep optimization focuses on individualized strategies to enhance sleep patterns and quality in order to promote overall well-being, prevent chronic conditions, and extend healthy lifespan. For example, in November 2024, AgelessRx Inc., a US-based longevity-oriented telehealth platform, introduced a new sleep health program that includes both a prescription sleep aid (Trazodone) and a natural over-the-counter supplement (Tran-Q Sleep). This program is designed to address key dimensions of sleep, including duration, quality, consistency, and timing, marking the company’s entry into the sleep health segment with a personalized, research-supported approach that positions sleep as a foundation of long-term health and longevity.

Major companies operating in the over-the-counter (otc) sleep aids medication market are Procter & Gamble Co., Bayer AG, Sanofi S.A., GlaxoSmithKline plc, Perrigo Company plc, Reckitt Benckiser Group plc, Church & Dwight Co. Inc., Prestige Consumer Healthcare Inc., Viatris Inc., Walgreens Boots Alliance Inc., CVS Health Corporation, Rite Aid Corporation, Hyland’s Inc., Natrol LLC, Pharmavite LLC (Nature Made), The Bountiful Company, i-Health Inc., Zarbee’s Naturals, Olly PBC, Unilever plc, Herbaland Naturals Inc., Garden of Life LLC, Nature’s Way Products LLC, Solaray Inc., Nature’s Bounty Co., Spring Valley (Walmart Private Label), Equate (Walmart Private Label), GNC Holdings Inc., Blackmores Limited, Himalaya Wellness Company, A.Vogel AG, Schwabe Group.

North America was the largest region in the over-the-counter (OTC) sleep aids medication market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the over-the-counter (otc) sleep aids medication market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the over-the-counter (otc) sleep aids medication market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Tariffs have influenced the otc sleep aids medication market by increasing costs for imported active ingredients, herbal extracts, and packaging materials used in supplements and formulations. Segments such as melatonin supplements, herbal products, and cbd-based sleep aids are most affected, particularly in regions like Asia-Pacific and North America that rely on global ingredient sourcing. These tariffs have led to pricing pressures and margin adjustments for manufacturers. However, they have also encouraged local sourcing, domestic manufacturing, and formulation innovation to reduce dependency on imports and improve supply chain resilience.

The over-the-counter (otc) sleep aids medication market research report is one of a series of new reports that provides over-the-counter (otc) sleep aids medication market statistics, including over-the-counter (otc) sleep aids medication industry global market size, regional shares, competitors with a over-the-counter (otc) sleep aids medication market share, detailed over-the-counter (otc) sleep aids medication market segments, market trends and opportunities, and any further data you may need to thrive in the over-the-counter (otc) sleep aids medication industry. This over-the-counter (otc) sleep aids medication market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Over-the-counter (OTC) sleep aids are medications that can be purchased without a prescription to help people fall asleep or enhance sleep quality. They are generally intended for short-term use and function by inducing drowsiness or helping regulate the sleep-wake cycle. These products may cause side effects and are not recommended for managing chronic sleep disorders without medical guidance.

The main types of OTC sleep aid medications include antihistamines, melatonin supplements, herbal supplements, and other categories. Antihistamines are drugs that block the action of histamine in the body to relieve allergy-related symptoms such as sneezing, itching, and a runny nose. They are also used to manage insomnia, provide anxiety relief, and address other conditions that impact sleep quality and duration. Over-the-counter sleep aid medications are distributed through various channels, including online platforms, supermarkets or hypermarkets, pharmacies and drugstores, and specialty health and wellness stores.

The over-the-counter (OTC) sleep aids medication market consists of sales of nervous system relaxants, hormonal regulators, sedative antihistamines, anxiolytic herbal remedies. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.